TEHRAN (FNA) - Deputy Head of Baqiyatallah University of Medical Sciences in Iran Ebrahim Motevallian said that the new home-made Noora coronavirus vaccine will be mass-produced in the near future.
“The difference between Noora and other vaccines is that it is not a virus itself and it is made of protein, which is a method that has received much attention in the world,” he added, noting that the vaccine can also be used as a booster to other coronavirus vaccines.
The home-made anti-coronavirus vaccine, Noora, has entered the second stage of clinical trials, a health official of the Islamic Revolution Guards Corps (IRGC) that is developing the vaccine said earlier this month.
IRGC’s Deputy Director for Health, Medical Education and Biological Defense Affairs Brigadier General Ahmad Abdollahi said that the second phase of the clinical trial of the recombinant Noora vaccine has started.
“We hope to make this vaccine available to the public once the second and third stages [of human trial] have been carried out,” he noted.
Noora vaccine, produced by Baqiyatallah University of Medical Sciences, was put on display during a ceremony in Tehran on June 27 in the presence of Chief Commander of the IRGC Major General Hossein Salami, Iran’s former health minister Saeed Namaki as well as other Iranian health officials.
The recombinant vaccine entered the first stage of human trial after 16 months of research work by Iranian scientists.